secwatch.observer — SEC 8-K summary
======================================

Issuer:     Valion Bio, Inc. (VBIO)
CIK:        0001787740
Form:       8-K
Filed at:   2023-07-06T23:59:59+00:00
Accession:  0000950170-23-032062
Event type: other
Sentiment:  neutral
Materiality: 0.20
Item codes: 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Tivic Health amends bylaws to adopt universal proxy rules and lower quorum threshold
--------------------------------------------------------------------------------

- Amended Bylaws to incorporate SEC Rule 14a-19 universal proxy requirements.
- Reduced quorum for stockholder meetings to one-third of outstanding shares entitled to vote.
- Amendment effective July 5, 2023; stockholder approval not required under Bylaws.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1787740/000095017023032062/0000950170-23-032062-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1787740/000095017023032062/tivc-20230705.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-032062

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer